Skip to content

5-Amino-1MQ

NNMT Inhibitor. Small molecule NNMT (nicotinamide N-methyltransferase) inhibitor. Blocks NNMT to elevate NAD+ and SAM, improve mitochondrial function, and reduce fat cell activity. Metabolic health, fat loss, NAD+ elevation.

Intelligence Profile

Research Papers

Research Papers and Clinical Trials

No published research was found for 5-Amino-1MQ in PubMed or clinical trial databases.

At the time of this analysis, there are no peer-reviewed research papers or registered clinical trials specifically investigating 5-Amino-1MQ available in major medical databases. This absence of published evidence means there is currently no scientific data on this compound's safety profile, efficacy, mechanism of action, or appropriate dosing in humans or animal models.

The lack of published research represents a significant knowledge gap. Without peer-reviewed studies, claims about this compound's effects, benefits, or risks cannot be verified through established scientific literature.

Disclaimer: This analysis is for informational purposes only and is not medical advice. The absence of published research means the safety and efficacy of this compound are unknown. Consult with a healthcare provider before considering any unproven treatments.

Free account required

Research papers requires a free AXIFI account to access clinical data, safety profiles, and research papers.